Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-28 @ 8:37 PM
Study NCT ID:
NCT01357135
Status:
COMPLETED
Last Update Posted:
2017-06-05
First Post:
2011-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2013-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-18
First Submit QC Date:
None
Study First Post Date:
2011-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-14
Results First Submit QC Date:
None
Results First Post Date:
2014-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-04
Last Update Post Date:
2017-06-05
Last Update Post Date Type:
ACTUAL